Dr. Conklin joins the Sheikh Zayed Institute from the FDA Office of New Drugs. She is a principal investigator for the institute’s Systems Biology Initiative and is director of the Inflammatory Bowel Disease Center at Children’s National Medical Center.
Her clinical interests are focused on better ways to detect and manage depression and anxiety in children with inflammatory bowel disease. She is also interested in nutritional issues related to IBD.
Related Articles on Gastroenterologists:
Gastroenterologist Dr. Vincent Jabour Highlights Benefits of ASCs to Congressman
Gastroenterologist on the Move: Dr. Magdalena Averhoff Appointed to Florida Board of Medicine
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
